Bioceptive and Trimedic have announced a letter of intent to establish a joint venture aimed at bringing the FDA-approved Cervical Suction Retractor (CSR) to market in Canada and the United States. The device offers an alternative to the traditional tenaculum used in gynecological procedures, including IUD insertion. The CSR uses gentle suction instead of the pinching mechanism of the tenaculum, which can…
Hologic has announced the completion of its acquisition of Gynesonics, a privately held medical device company focused on minimally invasive solutions for women’s health. The transaction, valued at approximately $350 million, brings Gynesonics’ Sonata System under Hologic’s portfolio of women’s health solutions. The Sonata System provides diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual…
Movano Health has received FDA 510(k) clearance for the pulse oximeter in its EvieMED Ring. The company states this clearance unlocks potential applications in clinical trials, post-clinical trial management, and remote patient monitoring for healthcare providers and payors. “We launched the Evie Ring in the consumer wearable market, but our broader goal has always been to provide a clinical-grade device for B2B…
Caldera Medical has announced the acquisition of UVision360, developer of the LUMINELLE hysteroscopy and cystoscopy systems. The deal expands Caldera’s portfolio in minimally invasive solutions for diagnosing and treating conditions such as polyps, fibroids, and intrauterine pathology. “We are excited to integrate LUMINELLE’s technology into Caldera Medical’s growing portfolio,” said Bryon Merade, CEO of Caldera Medical. “This acquisition strengthens our commitment to…
Hologic, a medtech company focused on women’s health, has announced a definitive agreement to acquire Gynesonics, a privately held medical device company. The acquisition is valued at approximately $350 million, subject to working capital and other customary closing adjustments. Gynesonics is known for developing the Sonata System, designed for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those…
Medtech company INNITIUS has announced promising results from its FineBirth Clinical Trial-1 (FB-CT1) for its novel Fine Birth device, designed to improve the diagnosis of threatened preterm labor (TPTL). Preterm birth, occurring in approximately 500,000 cases annually in the EU alone, is a critical public health issue responsible for over 1 million deaths each year globally. It remains the leading cause of…
You’ve found some of our exclusive Inner Circle Content. This article is only available for our Inner Circle Members. To read on: Sign in to your Inner Circle account to access this content. If you aren’t a member yet and would like to find out more about our Inner Circle program or sign up, click here.
Melodi Health, a medical device company based in Minneapolis, announced two significant milestones last week. The company successfully closed a $10.75 million oversubscribed Series A funding round and launched the “ARIA” investigational device exemption (IDE) trial, designed to improve outcomes for women undergoing breast reconstruction following mastectomy. The funds raised will support ongoing clinical activities and further product development. Melodi Health, founded…
